More than one half of Russians stated that they would not purchase COVID-19 medicines if they were costly, according to a survey conducted in the fourth quarter of 2020. Furthermore, approximately 45 percent held the view that such products should be available to purchase only with a prescription.
Opinion on medication against the coronavirus (COVID-19) in Russia in 4th quarter 2020, by statement
Loading statistic...
Basic Account
Get to know the platform
You only have access to basic statistics.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access
Corporate solution including all features.
* Prices do not include sales tax.
Further Content: You might find this interesting as well
Statistics
- Coronavirus-related share price changes in biopharma companies Jan-Feb 2020
- COVID-19-related research market cap changes in biopharma companies Feb 2020
- Sales value of pharmaceutical market in China 2018-2023
- Growth rate of pharmaceutical sales value in China 2018-2023
- Procurement of protection masks against the spread of COVID-19 in Romania 2020
- Forecasted quarterly sales value of pharmaceutical market in China 2020
- Forecasted growth rate of pharmaceutical sales value in China 2020, by quarter
- Hungarians on increasing healthcare equipment capacity during COVID-19 2020
- Home office possibilities due to coronavirus spread in Romania 2020
- Annual growth rate of pharmaceutical spending in Japan FY 2018-2024
- Clinical trials due to COVID-19 read out March 2020 worldwide, by stage
- Opinion on benefits of digital health during the COVID-19 outbreak in the UK 2020
- Knowledge of how to prevent getting infected with the coronavirus in Norway 2020
- Willingness to use digital health services due to coronavirus in the UK 2020
- Opinion on the effectiveness of hand soaps against COVID-19 U.S. 2020, by age
- Russians' actions in case of flu during COVID-19 in April 2020
DSM Group. (March 1, 2021). Opinion on medication against the coronavirus (COVID-19) in Russia in 4th quarter 2020, by statement [Graph]. In Statista. Retrieved August 19, 2022, from https://www.statista.com/statistics/1218413/opinion-on-covid-19-medicines-russia/
DSM Group. "Opinion on medication against the coronavirus (COVID-19) in Russia in 4th quarter 2020, by statement." Chart. March 1, 2021. Statista. Accessed August 19, 2022. https://www.statista.com/statistics/1218413/opinion-on-covid-19-medicines-russia/
DSM Group. (2021). Opinion on medication against the coronavirus (COVID-19) in Russia in 4th quarter 2020, by statement. Statista. Statista Inc.. Accessed: August 19, 2022. https://www.statista.com/statistics/1218413/opinion-on-covid-19-medicines-russia/
DSM Group. "Opinion on Medication against The Coronavirus (Covid-19) in Russia in 4th Quarter 2020, by Statement." Statista, Statista Inc., 1 Mar 2021, https://www.statista.com/statistics/1218413/opinion-on-covid-19-medicines-russia/
DSM Group, Opinion on medication against the coronavirus (COVID-19) in Russia in 4th quarter 2020, by statement Statista, https://www.statista.com/statistics/1218413/opinion-on-covid-19-medicines-russia/ (last visited August 19, 2022)